Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been
expanded to include pathways for treatment of microscopic satellitosis (added in v2. 2020) …

Critical to the clinical management of a patient with malignant melanoma is an
understanding of its natural history. As with most malignant disorders, prognosis is highly …

Background Most patients with melanoma have a thin (≤ 1.00 mm) lesion. There is
uncertainty as to which patients with thin melanoma should undergo sentinel lymph node …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Melanoma focuses on adjuvant therapy and treatment of in-transit disease, because …

Purpose Indications for sentinel lymph node biopsy (SLNB) for thin melanoma are
continually evolving. We present a large multi-institutional study to determine factors …

Purpose Most patients with melanoma have microscopically thin (≤ 1 mm) primary lesions
and are cured with excision. However, some develop metastatic disease that is often fatal …

Abstract Background: The late Dr. Vincent McGovern (1915 to 1983) was an international
authority on melanoma pathology and one of the first to suggest that assessment of tumor …

Purpose The majority of invasive primary melanomas are thin (≤ 1.00 mm). Since the
current staging system imperfectly predicts outcome in patients with such lesions, we sought …

Purpose Tumor cell proliferation is a central feature of melanoma progression. In this study,
we characterized three biomarkers of proliferation (Ki67 expression, dermal mitotic rate …

Malignant melanoma is one of the most common malignancies. Its incidence grows rapidly
at an annual rate of 3− 5%. Although the incidence of melanoma remains low in China, it …